Vamorolone Dosage
Medically reviewed by Drugs.com. Last updated on Mar 25, 2024.
Applies to the following strengths: 40 mg/mL
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Muscular Dystrophy
Recommended dose: 6 mg/kg orally once a day, preferably with a meal
Maximum daily dose (weight greater than 50 kg): 300 mg orally once a day
Comments:
- Dose may be titrated down to 2 mg/kg/day as needed based on individual tolerability and response.
- To minimize the risk of adrenal insufficiency, patients on oral corticosteroids (e.g., prednisone, deflazacort) can transition to therapy without dose reduction or interruption of the prior corticosteroid.
- Patients switching to this drug after long-term treatment with oral corticosteroids should start therapy at the recommended dose.
- If discontinuing therapy, decrease the dose gradually if the patient has been treated for more than 1 week.
Use: For the treatment of Duchenne muscular dystrophy
Usual Pediatric Dose for Muscular Dystrophy
2 YEARS OR OLDER:
Recommended dose: 6 mg/kg orally once a day, preferably with a meal
Maximum daily dose (weight greater than 50 kg): 300 mg orally once a day
Comments:
- Dose may be titrated down to 2 mg/kg/day as needed based on individual tolerability and response.
- To minimize the risk of adrenal insufficiency, patients on oral corticosteroids (e.g., prednisone, deflazacort) can transition to therapy without dose reduction or interruption of the prior corticosteroid.
- Patients switching to this drug after long-term treatment with oral corticosteroids should start therapy at the recommended dose.
- If discontinuing therapy, decrease the dose gradually if the patient has been treated for more than 1 week.
Use: For the treatment of Duchenne muscular dystrophy
Renal Dose Adjustments
Renal dysfunction: Data not available
Liver Dose Adjustments
Mild or Moderate Liver Dysfunction (Child-Pugh A or B): 2 mg/kg orally once a day, preferably with a meal
- Maximum daily dose (weight greater than 50 kg): 100 mg orally once a day; dose may be titrated down based on individual tolerability.
Dose Adjustments
Use with Strong CYP450 3A4 Inhibitors: Reduce to 4 mg/kg orally once a day, preferably with a meal
- Maximum daily dose (weight greater than 50 kg): 200 mg orally once a day; dose may be titrated down based on individual tolerability.
Precautions
CONTRAINDICATIONS:
- Hypersensitivity to either the active component or to any of the ingredients; instances of hypersensitivity, including anaphylaxis, have occurred in patients receiving corticosteroid therapy
Safety and efficacy have not been established in patients younger than 2 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- Prior to therapy, administer all guideline-recommended immunizations; live-attenuated or live vaccines should be given at least 4 to 6 weeks before starting this drug.
- Administer treatment once a day, preferably with a meal, and dispense directly into the mouth.
- Before administration, shake oral suspension well for 30 seconds and only use the oral syringe provided for dosing.
- Do not mix this drug with any type of liquids prior to administration.
Storage requirements:
- Store bottle upright at room temperature between 20C to 25C (68F to 77F).
- Temperature excursions permitted between 15C to 30C (59F to 86F) while in the original carton.
- After opening, store bottle upright in a refrigerator at 2C to 8C (36F to 46F); do not freeze.
- Discard any unused suspension 3 months after first opening the bottle.
General:
- Duchenne muscular dystrophy is mostly a disease of children and young adults; there is no experience with this drug in older adults.
Monitoring:
- Cardiovascular: Blood pressure and for volume overload (during therapy)
- Endocrine: For signs/symptoms of Cushing's syndrome and adrenal insufficiency (after withdrawal of this drug)
- Hepatic: Hepatitis B (prior to therapy)
- Infections/Infestations: Amebiasis (prior to therapy), and for the development of or exposure to infections, including fungal, Strongyloides, varicella, and/or measles (during therapy)
- Metabolic: Blood glucose (regularly during therapy); for hyperglycemia (after withdrawal of this drug); serum potassium/sodium levels (during long-term therapy)
- Musculoskeletal: For decreases in bone mineral density (during long-term therapy)
- Ocular: Intraocular pressure (for treatment longer than 6 weeks)
Patient advice:
- Read the US FDA-approved patient labeling (Instructions for Use).
- Do not stop this drug abruptly or without first consulting health care providers.
- Inform your health care provider regarding recent or ongoing infections; some infections can be severe and/or fatal.
- Avoid exposure to chickenpox or measles; if exposed, notify health care provider immediately.
- Seek medical attention if psychiatric symptoms (especially depressed mood or suicidal ideation) develop.
- Understand that intraocular pressure should be monitored during long term therapy.
- Avoid the use of live-attenuated or live vaccines during treatment.
- Inform your health care provider of all the medications you are taking, including over-the-counter medications.
More about vamorolone
- Check interactions
- Compare alternatives
- Side effects
- During pregnancy
- Drug class: glucocorticoids
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
See also:
Elevidys
Elevidys is a gene therapy for Duchenne muscular dystrophy, that is given as a one-time infusion ...
Duvyzat
Duvyzat (givinostat) is used to treat Duchenne muscular dystrophy (DMD) to delay symptoms and ...
Amondys 45
Amondys 45 (casimersen) is used to treat Duchenne muscular dystrophy (DMD) with a genetic mutation ...
Exondys 51
Exondys 51 is used for Duchenne Muscular Dystrophy (DMD) in children and young adults with a ...
Emflaza
Emflaza (deflazacort) is a corticosteroid medication used to treat a rare genetic disorder called ...
Vyondys 53
Vyondys 53 is used for Duchenne muscular dystrophy (DMD) in children and young adults with a ...
Agamree
Agamree (vamorolone) is an FDA-approved treatment for Duchenne muscular dystrophy (DMD) to improve ...
Eteplirsen
Eteplirsen is used for Duchenne Muscular Dystrophy (DMD) in children and young adults with a gene ...
Golodirsen
Golodirsen is used to treat Duchenne muscular dystrophy (DMD) in children and young adults with a ...
Givinostat
Givinostat (Duvyzat) is used to treat Duchenne muscular dystrophy (DMD) to delay symptoms and ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.